A retrospective study evaluates the efficacy of pazopanib in treating recurrent central nervous system solitary fibrous tumors. The findings contribute to understanding treatment options for this rare tumor type.
pazopanib for recurrent central nervous system solitary fibrous tumors a single institution retrospective series
Original title: “Pazopanib for recurrent central nervous system solitary fibrous tumors: A single-institution retrospective series.”